FDA authorizes AstraZeneca’s preventative COVID-19 antibody treatment
The US Food and Drug Administration (FDA) has authorized the first COVID-19 drug designed to prevent infection in vulnerable and immunocompromised populations. The monoclonal antibody treatment is delivered by intramuscular injection and offers robust … Continue reading FDA authorizes AstraZeneca’s preventative COVID-19 antibody treatment